1. Denys P, Malvaux P, Van Den Berghe H, Tanghe W, Proesmans W. Association of an anatomo-pathological syndrome of male pseudohermaphroditism, Wilms' tumor, parenchymatous nephropathy and XX/XY mosaicism. Arch Fr Pediatr 1967;24:729–739. PMID:
4292870.
2. Drash A, Sherman F, Hartmann WH, Blizzard RM. A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease. J Pediatr 1970;76:585–593. PMID:
4316066.
3. Armstrong JF, Pritchard-Jones K, Bickmore WA, Hastie ND, Bard JB. The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. Mech Dev 1993;40:85–97. PMID:
8382938.
4. Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, et al. The candidate Wilms' tumour gene is involved in genitourinary development. Nature 1990;346:194–197. PMID:
2164159.
5. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, et al. WT-1 is required for early kidney development. Cell 1993;74:679–691. PMID:
8395349.
6. Bruening W, Bardeesy N, Silverman BL, Cohn RA, Machin GA, Aronson AJ, et al. Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development. Nat Genet 1992;1:144–148. PMID:
1302008.
7. Shimamura R, Fraizer GC, Trapman J, Lau YfC, Saunders GF. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor. Clin Cancer Res 1997;3(12 Pt 2):2571–2580. PMID:
9815658.
8. Munsterberg A, Lovell-Badge R. Expression of the mouse anti-müllerian hormone gene suggests a role in both male and female sexual differentiation. Development 1991;113:613–624. PMID:
1782869.
9. Belville C, Josso N, Picard JY. Persistence of Müllerian derivatives in males. Am J Med Genet 1999;89:218–223. PMID:
10727997.
10. Hossain A, Saunders GF. Role of Wilms tumor 1 (WT1) in the transcriptional regulation of the Mullerian-inhibiting substance promoter. Biol Reprod 2003;69:1808–1814. PMID:
12855602.
11. Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, et al. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991;67:437–447. PMID:
1655284.
12. Baird PN, Santos A, Groves N, Jadresic L, Cowell JK. Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome. Hum Mol Genet 1992;1:301–305. PMID:
1338906.
13. Little MH, Williamson KA, Mannens M, Kelsey A, Gosden C, Hastie ND, et al. Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion. Hum Mol Genet 1993;2:259–264. PMID:
8388765.
14. Nordenskjold A, Fricke G, Anvret M. Absence of mutations in the WT1 gene in patients with XY gonadal dysgenesis. Hum Genet 1995;96:102–104. PMID:
7607640.
15. Little M, Wells C. A clinical overview of WT1 gene mutations. Hum Mutat 1997;9:209–225. PMID:
9090524.
16. Takata A, Kikuchi H, Fukuzawa R, Ito S, Honda M, Hata J. Constitutional WT1 correlate with clinical features in children with progressive nephropathy. J Med Genet 2000;37:698–701. PMID:
11182928.